RNA Atrium Therapeutics, Inc.
Healthcare$13.09+0.38%ClosedMarket Cap: $223.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$25.00
Target (Median)
$25.00
Target Range
$25.00 - $25.00
Upside from current price: 91.0%
Rating Distribution
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-11-11 | Chardan Capital | maintain | Neutral | Neutral |
| 2025-10-29 | TD Cowen | downgrade | Hold | Buy |
| 2025-10-28 | RBC Capital | downgrade | Sector Perform | Outperform |
| 2025-10-27 | Raymond James | downgrade | Market Perform | Strong Buy |
| 2025-10-27 | Needham | downgrade | Hold | Buy |
| 2025-10-27 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-10-27 | Citigroup | downgrade | Neutral | Buy |
| 2025-10-27 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2025-10-27 | Bernstein | downgrade | Market Perform | Outperform |
| 2025-09-22 | Evercore ISI Group | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-4.14 | $8.0M | 4 |
| Fri Dec 31 | $-5.49 | $4.0M | 4 |
| Sun Dec 31 | $-5.89 | $8.0M | 6 |
| Mon Dec 31 | $-4.24 | $1.61B | 4 |